Maria Sabater Molina-rekin lankidetzan egindako argitalpenak (47)

2024

  1. Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry

    European heart journal, Vol. 45, Núm. 16, pp. 1443-1454

  2. Concurrent Resistance and Cardiorespiratory Training in Patients with Hypertrophic Cardiomyopathy: A Pilot Study

    Journal of Clinical Medicine, Vol. 13, Núm. 8

  3. Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term Registry

    European Heart Journal, Vol. 45, Núm. 28, pp. 2548-2569

  4. In recognition of the Spanish origin of CRISPR/Cas9. Implications for the treatment of familial heart disease

    Revista Espanola de Cardiologia

  5. In recognition of the Spanish origin of CRISPR/Cas9. Implications for the treatment of familial heart disease

    Revista Española de Cardiología (English Edition)

2023

  1. A Human Hereditary Cardiomyopathy Shares a Genetic Substrate With Bicuspid Aortic Valve

    Circulation, Vol. 147, Núm. 1, pp. 47-65

  2. An Embedding Approach for Biomarker Identification in Hypertrophic Cardiomyopathy

    Computing in Cardiology

  3. Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry

    European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9, Núm. 1, pp. 42-53

  4. Current therapies for hypertrophic cardiomyopathy: a systematic review and meta-analysis of the literature

    ESC Heart Failure, Vol. 10, Núm. 1, pp. 8-23

2022

  1. Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility (Nature Genetics, (2022), 54, 3, (232-239), 10.1038/s41588-021-01007-6)

    Nature Genetics

  2. Evidence for reciprocal network interactions between injured hearts and cancer

    Frontiers in Cardiovascular Medicine, Vol. 9

  3. Natural History of MYH7-Related Dilated Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 80, Núm. 15, pp. 1447-1461

  4. Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease

    PloS one, Vol. 17, Núm. 2, pp. e0263140

  5. Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease

    PLoS ONE, Vol. 17, Núm. 2 February

  6. The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure

    Cardiovascular research, Vol. 118, Núm. 6, pp. 1466-1478

2021

  1. Association of Genetic Variants With Outcomes in Patients With Nonischemic Dilated Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 78, Núm. 17, pp. 1682-1699

  2. Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry

    ESC Heart Failure, Vol. 8, Núm. 1, pp. 95-105

  3. Electrocardiographic Screening of Arrhythmogenic Cardiomyopathy in Genotype-Positive and Phenotype-Negative Relatives

    Frontiers in Cardiovascular Medicine, Vol. 8

  4. Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls

    Genetics in Medicine, Vol. 23, Núm. 1, pp. 47-58

  5. Prevented Sudden Cardiac Death and Neurologic Recovery in Inherited Heart Diseases

    Frontiers in Cardiovascular Medicine, Vol. 8